Header Logo

ALBERT RAIZNER

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address6550 Fannin Suite 2021
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Raizner AE, Young JB. Constantly Bombarded with New Drugs: What's a Cardiologist to Do? Methodist Debakey Cardiovasc J. 2022; 18(5):74-76. PMID: 36561079; PMCID: PMC9733149.
      Citations:    Fields:    
    2. Young JB, Raizner AE. Cardiovascular Pharmacology: Contemporary Physiologic and Scientific Approaches to Cardiovascular Disease Prevention and Treatment. Methodist Debakey Cardiovasc J. 2022; 18(5):1-4. PMID: 36561086; PMCID: PMC9733162.
      Citations:    Fields:    
    3. Raizner AE, Qui?ones MA. Coenzyme Q10 for Patients With Cardiovascular Disease: JACC Focus Seminar. J Am Coll Cardiol. 2021 02 09; 77(5):609-619. PMID: 33538259.
      Citations: 5     Fields:    Translation:Humans
    4. Haenel A, Ghosn M, Karimi T, Vykoukal J, Shah D, Valderrabano M, Schulz DG, Raizner A, Schmitz C, Alt EU. Unmodified autologous stem cells at point of care for chronic myocardial infarction. World J Stem Cells. 2019 Oct 26; 11(10):831-858. PMID: 31692971; PMCID: PMC6828597.
      Citations: 7     
    5. Raizner AE, Cooke JP. Dietary Supplements: Facts and Fallacies. Methodist Debakey Cardiovasc J. 2019 Jul-Sep; 15(3):169-170. PMID: 31687094; PMCID: PMC6822645.
      Citations: 1     Fields:    Translation:Humans
    6. Sunkara A, Raizner A. Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment. Methodist Debakey Cardiovasc J. 2019 Jul-Sep; 15(3):179-184. PMID: 31687096; PMCID: PMC6822653.
      Citations: 10     Fields:    Translation:Humans
    7. Raizner AE. Coenzyme Q10. Methodist Debakey Cardiovasc J. 2019 Jul-Sep; 15(3):185-191. PMID: 31687097; PMCID: PMC6822644.
      Citations: 15     Fields:    Translation:HumansAnimals
    8. Alviar CL, Tellez A, Wang M, Potts P, Smith D, Tsui M, Budzynski W, Raizner AE, Kleiman NS, Lev EI, Granada JF, Kaluza GL. Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo. J Thromb Thrombolysis. 2012 Jul; 34(1):91-8. PMID: 22350685.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    9. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012 Mar 15; 366(11):991-9. PMID: 22417252.
      Citations: 224     Fields:    Translation:HumansPHPublic Health
    10. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSURE I Investigators. Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke. 2010 Dec; 41(12):2872-83. PMID: 21051670.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    11. Novack V, Cutlip D, Kleiman N, Pencina M, Mauri L, Yen CH, Berger P, Goldberg S, Kellett M, Waksman R, Hong M, Raizner AE, Cohen DJ. In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009 Aug; 2(8):767-75. PMID: 19695546.
      Citations:    Fields:    Translation:Humans
    12. Raizner AE. Magnetic navigation: a pivotal technology. Catheter Cardiovasc Interv. 2007 May 01; 69(6):856. PMID: 17427904.
      Citations: 1     Fields:    Translation:Humans
    13. Weisz G, Moses JW, Teirstein PS, Holmes DR, Raizner AE, Satler LF, Mishkel G, Wilensky RL, Wang P, Kuntz RE, Popma JJ, Leon MB. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy). Am J Cardiol. 2007 Apr 15; 99(8):1044-50. PMID: 17437725.
      Citations: 3     Fields:    Translation:Humans
    14. Granada JF, Wallace-Bradley D, Win HK, Alviar CL, Builes A, Lev EI, Barrios R, Schulz DG, Raizner AE, Kaluza GL. In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol. 2007 Feb; 27(2):387-93. PMID: 17138936.
      Citations: 25     Fields:    Translation:Animals
    15. Hirohata A, Morino Y, Ako J, Sakurai R, Buchbinder M, Caputo RP, Karas SP, Mishkel GJ, Mooney MR, O'shaughnessy CD, Raizner AE, Wilensky RL, Williams DO, Wong SC, Yock PG, Honda Y, Moses JW, Fitzgerald PJ, DIRECT Investigators. Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial). Am J Cardiol. 2006 Dec 01; 98(11):1464-7. PMID: 17126651.
      Citations: 1     Fields:    Translation:Humans
    16. Lev EI, Tayyan N, Raizner AE, Solomon SL, Simmons D, Kleiman NS. Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coron Artery Dis. 2006 May; 17(4):379-84. PMID: 16707962.
      Citations: 1     Fields:    Translation:Humans
    17. Rodriguez AE, Granada JF, Vigo CF, Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo AM, Schulz D, Raizner AE, Palacios I, O'Neill W, Kaluza GL, Stone G, ORAR II Investigators, Rodriguez-Alemparte M. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study. J Am Coll Cardiol. 2006 Apr 18; 47(8):1522-9. PMID: 16630986.
      Citations: 10     Fields:    Translation:Humans
    18. Atmakuri SR, Lev EI, Alviar C, Ibarra E, Raizner AE, Solomon SL, Kleiman NS. Initial experience with a magnetic navigation system for percutaneous coronary intervention in complex coronary artery lesions. J Am Coll Cardiol. 2006 Feb 07; 47(3):515-21. PMID: 16458129.
      Citations: 5     Fields:    Translation:Humans
    19. Granada JF, Ensenat D, Keswani AN, Kaluza GL, Raizner AE, Liu XM, Peyton KJ, Azam MA, Wang H, Durante W. Single perivascular delivery of mitomycin C stimulates p21 expression and inhibits neointima formation in rat arteries. Arterioscler Thromb Vasc Biol. 2005 Nov; 25(11):2343-8. PMID: 16141400.
      Citations: 9     Fields:    Translation:AnimalsCells
    20. Granada JF, Moreno PR, Burke AP, Schulz DG, Raizner AE, Kaluza GL. Endovascular needle injection of cholesteryl linoleate into the arterial wall produces complex vascular lesions identifiable by intravascular ultrasound: early development in a porcine model of vulnerable plaque. Coron Artery Dis. 2005 Jun; 16(4):217-24. PMID: 15915073.
      Citations: 7     Fields:    Translation:Animals
    21. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW, TAXUS-IV Investigators. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol. 2005 Apr 19; 45(8):1172-9. PMID: 15837245.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    22. Buergler JM, Maliszewski CR, Broekman MJ, Kaluza GL, Schulz DG, Marcus AJ, Raizner AE, Kleiman NS, Ali NM. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis. 2005 Apr; 19(2):115-22. PMID: 16052302.
      Citations: 10     Fields:    Translation:HumansAnimals
    23. Conklin LD, McAninch RE, Schulz D, Kaluza GL, LeMaire SA, Coselli JS, Raizner AE, Sutton RE. HIV-based vectors and angiogenesis following rabbit hindlimb ischemia. J Surg Res. 2005 Jan; 123(1):55-66. PMID: 15652951.
      Citations: 6     Fields:    Translation:AnimalsCells
    24. Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Comparison of quantitative angiographic parameters with the magnitude of neointimal hyperplasia measured by volumetric intravascular ultrasound in patients treated with bare metal and nonpolymeric paclitaxel-coated stents. Am J Cardiol. 2005 Jan 01; 95(1):105-7. PMID: 15619403.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    25. Mintz GS, Hong MK, Raizner AE, Lee CW, Kim JJ, Escolar E, Fearnot NE, Park SW, Park SJ, Weissman NJ. Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. Am J Cardiol. 2005 Jan 01; 95(1):107-9. PMID: 15619404.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    26. Kaluza GL, Raizner AE. Brachytherapy for restenosis after stenting for coronary artery disease: its role in the drug-eluting stent era. Curr Opin Cardiol. 2004 Nov; 19(6):601-7. PMID: 15502506.
      Citations: 2     Fields:    Translation:Humans
    27. Kaluza GL, Gershlick AH, Park SJ, De Scheerder I, Chevalier B, Camenzind E, Goy JJ, Missault L, Reifart N, Vrints C, Urban P, Shim WH, Ho DS, Fearnot NE, Voorhees WD, Raizner AE. Comparison of neointimal formation in polymer-free paclitaxel stents versus stainless stents (from the ASPECT and ELUTES randomized clinical trials). Am J Cardiol. 2004 Jul 15; 94(2):199-201. PMID: 15246901.
      Citations: 1     Fields:    Translation:Humans
    28. Granada JF, Kaluza GL, Raizner AE, Moreno PR. Vulnerable plaque paradigm: prediction of future clinical events based on a morphological definition. Catheter Cardiovasc Interv. 2004 Jul; 62(3):364-74. PMID: 15224306.
      Citations: 4     Fields:    Translation:HumansAnimals
    29. Gershlick A, De Scheerder I, Chevalier B, Stephens-Lloyd A, Camenzind E, Vrints C, Reifart N, Missault L, Goy JJ, Brinker JA, Raizner AE, Urban P, Heldman AW. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial. Circulation. 2004 Feb 03; 109(4):487-93. PMID: 14744971.
      Citations: 31     Fields:    Translation:HumansCTClinical Trials
    30. Plana JC, Iskander SS, Ostrowski ML, Howell JF, Kurrelmeyer K, Raizner AE, Zoghbi WA. Cardiac angiosarcoma: an unusual presentation simulating mitral stenosis and constrictive-effusive pericarditis. J Am Soc Echocardiogr. 2003 Dec; 16(12):1331-3. PMID: 14652616.
      Citations: 3     Fields:    Translation:Humans
    31. Okura H, Lee DP, Lo S, Yeung AC, Honda Y, Waksman R, Kaluza GL, Ali NM, Bonneau HN, Yock PG, Raizner AE, Mintz GS, Fitzgerald PJ. Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy. Am J Cardiol. 2003 Sep 01; 92(5):587-90. PMID: 12943881.
      Citations: 1     Fields:    Translation:Humans
    32. Granada JF, Kaluza GL, Raizner A. Drug-eluting stents for cardiovascular disorders. Curr Atheroscler Rep. 2003 Jul; 5(4):308-16. PMID: 12793972.
      Citations: 3     Fields:    Translation:Humans
    33. Costantini CO, Lansky AJ, Mintz GS, Shirai K, Teirstein PS, Stone G, Vandertie L, Proctor B, Fahy M, Yeung A, Raizner AE, Waksman R, Leon MB, INHIBIT trial. Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial. Am J Cardiol. 2003 May 15; 91(10):1261-5. PMID: 12745117.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    34. Shirai K, Lansky AJ, Mintz GS, Costantini CO, Cristea E, Fahy M, Vandertie L, Yeung A, Raizner AE, Waksman R, Leon MB. Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent Trial. Am J Cardiol. 2003 May 01; 91(9):1113-5. PMID: 12714158.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    35. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med. 2003 Apr 17; 348(16):1537-45. PMID: 12700373.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    36. Waksman R, Raizner A, Popma JJ. Beta emitter systems and results from clinical trials. state of the art. Cardiovasc Radiat Med. 2003 Apr-Jun; 4(2):54-63. PMID: 14581084.
      Citations: 2     Fields:    Translation:Humans
    37. Nguyen-Ho P, Kaluza GL, Zymek PT, Raizner AE. Intracoronary brachytherapy. Catheter Cardiovasc Interv. 2002 Jun; 56(2):281-8. PMID: 12112930.
      Citations:    Fields:    Translation:Humans
    38. Beusterien KM, Plante KM, Waksman R, Raizner AE, Annis M, Goss TF. The cost-effectiveness of beta-radiation therapy for treatment of in-stent restenosis: an analysis at 290-day follow-up. Cardiovasc Radiat Med. 2002 Apr-Jun; 3(2):107-13. PMID: 12699841.
      Citations:    Fields:    Translation:Humans
    39. Fernandes V, Kaluza GL, Zymek PT, DeFelice CA, Hust R, Raizner AE. Successful balloon valvuloplasty in an adult patient with severe pulmonic stenosis and aneurysmal poststenotic dilatation. Catheter Cardiovasc Interv. 2002 Mar; 55(3):376-80. PMID: 11870946.
      Citations:    Fields:    Translation:Humans
    40. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet. 2002 Feb 16; 359(9306):551-7. PMID: 11867107.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    41. Kaluza GL, Jenkins TP, Mourtada FA, Ali NM, Lee DP, Okura H, Fitzgerald PJ, Raizner AE. Targeting the adventitia with intracoronary beta-radiation: comparison of two dose prescriptions and the role of centering coronary arteries. Int J Radiat Oncol Biol Phys. 2002 Jan 01; 52(1):184-91. PMID: 11777637.
      Citations:    Fields:    Translation:Humans
    42. Raizner AE, Kaluza GL. The Proliferation REduction with Vascular ENergy Trial (PREVENT). Curr Control Trials Cardiovasc Med. 2001; 2(1):16-19. PMID: 11806768; PMCID: PMC59647.
      Citations:    
    RAIZNER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (205)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _